Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma Interventions: Drug: Orelabrutinib; Drug: Rituximab; Drug: Methotrexate Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials